Skip to content

Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study

Demonstration of the StarGuide GX SPECT/CT System

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07725237
Enrollment
30
Registered
2026-07-24
Start date
2026-07-20
Completion date
2027-02-01
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SPECT-CT

Brief summary

The goal of this study is to collect image data for the StarGuide GX Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) System in a clinical setting. The StarGuide GX scan will be compared to the participant's clinically indicated SPECT/CT scanner.

Interventions

DEVICEStarGuide GX SPECT/CT Scan

Participants will undergo two SPECT/CT scans and will be randomized to determine whether imaging with the StarGuide GX scanner or the commercially released reference scanner is performed first. The second scan will begin within one hour of completion of the first scan. No additional tracer will be administered prior to the second imaging session, as both scans will utilize the initially administered dose. Following completion of both scans, participants will be asked to complete a brief questionnaire.

Sponsors

GE Healthcare
Lead SponsorINDUSTRY
Rambam Health Care Campus
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult, who is at least 18 years of age, on day of consent. * Must have a clinically indicated SPECT/CT exam scheduled according to current clinical practice standards; AND * Able and willing to provide informed consent for participation in this study.

Exclusion criteria

* Who, per the site's Standard Operating Procedures (SOPs), has any condition that would prevent the clinically indicated SPECT/CT from proceeding (i.e., pregnancy, breastfeeding, renal impairment, etc.); * Who were previously enrolled in this study; * Who need urgent or emergent care; * Who have any conditions that, in the opinion of the Principal Investigator (PI) or designee, would interfere with the evaluation of the results, or constitute a health hazard for the participant; * Unwilling to have GE Healthcare personnel present during scans; OR * Unable to tolerate the exam.

Design outcomes

Primary

MeasureTime frame
Number of StarGuide GX Data Files CollectedThrough study completion, an average of 1 year

Secondary

MeasureTime frame
Number of reference data filesThrough study completion, an average of 1 year
Number of Participant Questionnaires CollectedThrough study completion, an average of 1 year

Countries

Israel

Contacts

CONTACTErin Terrell, MS
erin.terrell@gehealthcare.com1 262 449 3363
STUDY_DIRECTORBrian Thomsen

GE Healthcare

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026